AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva’s latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
(Adnkronos) – BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ — AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service to the world using
